The enforcement scale is real: more than 455 FDA adverse-event reports tied to compounded semaglutide, over 50 warning letters to compounded GLP-1 sellers in 2025, and 30-plus more in March 2026, several of them naming the compounding pharmacies behind telehealth brands
Our products are certified with MSDS, FDA, and CE standards
Who Should Be Cautious Anyone who is pregnant or breastfeeding, unless a clinician specifically approves it
Some people maintain the benefits for several weeks, while others schedule maintenance sessions to keep their energy and focus steady
Safety concerns include common gastrointestinal side effects, such as nausea and vomiting, as well as potential risks related to the pancreas, gallbladder, and thyroid C-cell tumors